Wedbush Starts Varian Medical (VAR) at Outperform; Delivering the Right Dose of Radiation

December 30, 2010 8:44 AM EST Send to a Friend
Wedbush initiates coverage on Varian Medical (NYSE: VAR) with a Outperform. PT $80.

Wedbush analyst says, "Leadership plus new product ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login